Career Enhancement Program

职业提升计划

基本信息

批准号：
10251120
负责人：
ANIL K SOOD
金额：
$ 7.44万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-22 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10251120
关键词：
Advocacy American Association of Cancer Research American Society of Clinical Oncology Award Basic Science Budgets Cancer Biology Cancer Center Cancer Research Project Clinical Clinical Research Collaborations Development Development Plans Diagnosis Disease Doctor of Medicine Early Diagnosis Early treatment Ensure Faculty Fostering Foundations Funding Goals Grant Healthcare Institution International Intervention Laboratories Leadership Malignant neoplasm of ovary Manuscripts Mentors Mentorship Minority Monitor Morbidity - disease rate Nanotechnology Ovarian Paper Patients Peer Review Prevention Publishing Research Research Personnel Resources Scientist Texas Training Translating Translational Research United States National Institutes of Health Woman Work Writing anticancer research base bench to bedside cancer diagnosis career career development clinical care design experience improved innovation investigator training meetings member mortality next generation novel programs recruit role model success supportive environment symposium translational approach

项目摘要

Career Enhancement Program SUMMARY/ABSTRACT The central goal of the Career Enhancement Program (CEP) is to use the resources at MD Anderson to train exceptional young investigators who will reduce the morbidity and mortality from ovarian cancer through making advances in the early detection, prevention, and treatment of this disease. To achieve this goal, the SPORE CEP will provide two awards, each of $50,000 annually for two years, funded from the SPORE and matching funds from MD Anderson. The intent of each CEP award is to prepare the selected scientists to become international leaders in academic research relevant to ovarian cancer. We will achieve this by aggressive recruitment of the most promising young investigators and the institution of an individualized development plan with clinical and a laboratory mentors and a mentoring committee, formal course work, coaching in grant and paper writing, leadership training, attendance at national meetings, networking with ovarian cancer scholars and completing and publishing a translational ovarian cancer research program. During our past SPORE awards, the CEP has developed the careers of 21 young investigators. In the first year of the original grant, three postdoctoral trainees received CE awards, and of the 18 faculty members supported since 2000, all have remained in academic research and 13 are engaged predominantly in ovarian cancer research. Ten have achieved peer-reviewed funding and two additional awardees have received competitive foundation grants. The six awardees in the most recently funded cycle received one R01, one R03, two CPRIT awards, two Texas Center for Nanotechnology Grants, one Liz Tilberis Scholar Award from the Ovarian Cancer Research Fund and one Susan Poorman Blackie Ovarian Cancer grant. After entering the program, awardees have published over 500 peer-reviewed papers regarding ovarian cancer. Of the faculty awardees, five are project leaders, co-investigators, collaborators or core leaders on the current SPORE (Drs. Anil Sood, Jinsong Liu, KK Wong, Vikas Kundra, and Guang Peng). Moving forward, the CEP will be led by Dr. Anil Sood, who is an outstanding role model and most effective mentor.

职业增强计划摘要/摘要职业增强计划（CEP）的核心目标是使用MD Anderson的资源来培训杰出的年轻调查员将通过在早期发现，预防和治疗该疾病方面取得了进步。为了实现这一目标，孢子CEP将提供两个奖项，每年两年的$ 50,000，由孢子和来自MD Anderson的资金。每个CEP奖的目的是准备选定的科学家成为与卵巢癌有关的学术研究领导者。我们将通过对最有前途的年轻调查员的积极招募和个性化的机构与临床和实验室导师以及指导委员会的制定计划，正式课程工作，在赠款和纸质写作，领导培训，参加全国会议的出席，与网络的指导教练卵巢癌学者，完成和发布一项转化卵巢癌研究计划。在过去的孢子奖中，CEP发展了21名年轻调查人员的职业生涯。第一年在原始赠款中，三名博士后学员获得了CE奖，其中18位教职员工支持自2000年以来，所有人都一直参与学术研究，其中13个主要参与卵巢癌研究。十个已经实现了经同行评审的资金，另外两名获奖者获得了竞争力基金会赠款。最近有资金的周期中的六位获奖者获得了一名R01，一个R03，两个CPRIT 奖项，两个德克萨斯州纳米技术赠款中心，卵巢的一项Liz Tilberis Scholar奖癌症研究基金和一项Susan Poorman Blackie卵巢癌。输入程序后，获奖者发表了有关卵巢癌的500多个同行评审的论文。教师的获奖者五名是当前孢子的项目负责人，共同研究人员，合作者或核心领导者（Drs。AnilSood， Jinsong Liu，Kk Wong，Vikas Kundra和Guang Peng）。前进，CEP将由Anil Sood博士领导，谁是杰出的榜样和最有效的导师。